After a recent top-deck reshuffle at its international operations, Mumbai-based Sun Pharma?s promoter Dilip Shanghvi has rejigged top executives handling…
Fast-tracks branded stores? launch, plans 500 ?Medicines Plus More? shops by year end.
Last week, Sun Pharmaceutical Industries? move to take full control of Israel?s Taro Pharma hit a roadblock when a special…
Tata Chemicals, the world?s second-largest soda ash manufacturer and India?s largest branded salt maker, is creating a holding company based…
Greater production in west coast fields, faster appraisals in east coast blocks planned.
The consortium comprising Gujarat State Petroleum Corporation, Oil and Natural Gas Corporation, Bharat Petroleum and Oil India is likely to…
India?s largest private power producer Tata Power plans to add 1,000 MW to take its planned capacity to 26,000 MW,…
Despite abandoning a bid for the UK?s Cable & Wireless Worldwide, telecom and enterprise IT services provider Tata Communications is…
Ajay Piramal-led Piramal Healthcare is targeting a five-fold growth in revenues by 2017 through its focus on five sectors, a…
Piramal Healthcare is in talks to buy US contract drug manufacturer Cambridge Major Laboratories for around $200 million, a person…
German pharma major, the 13.2-billion-euro Boehringer Ingelheim is launching diabetes drug linagliptin in India as part of a unique global…
Shankar Suryanarayanan was the first head of India operations at Japan?s largest pharmaceutical company, Takeda.
Although the R7.50 a litre hike in petrol prices effected by oil marketing companies will bring down their under-recoveries by…
As key stakeholders in the pharma industry ? associations of drug makers, drug retailers and civil society groups ? meet…
Selling fuel below cost is driving state-owned oil marketing companies to the brink as it shrinks profits, boosts interest payments…
Chairman and managing director of Cipla, YK Hamied, has cited ?humanitarian approach? behind his move to slash prices of some…
To purchase cardiology imaging companies & expand manufacturing park in Chennai.
Investors are watching how Piramal Healthcare, which sold its domestic drug business to US-based Abbott Laboratories in a $3.8-billion deal…
